Alzheimer's Therapeutics Market | AbbVie Inc. Teva Pharmaceuticals Ltd., Eisai Co. Ltd., Janssen Pharmaceuticals Inc. | By 2032
The global Alzheimer’s Therapeutics Market growth is anticipated to reach US$ 2.8 billion in 2022 and grow at a CAGR of 9.3% to US$ 6.8 billion by 2032. In 2021, Donepezil will hold the top spot in the global medication market with a share of 68.4%, according to a recent analysis by Future Market Insights.Alzheimer’...